SULFATEQ B V has a total of 35 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are INNOCRIN PHARMACEUTICALS INC, SOSEI CO LTD and HOEKSTRA WILLIAM J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 3 | |
#5 | Australia | 2 | |
#6 | Mexico | 2 | |
#7 | Netherlands | 2 | |
#8 | Brazil | 1 | |
#9 | Chile | 1 | |
#10 | China | 1 | |
#11 | Hungary | 1 | |
#12 | Serbia | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Van Der Graaf Adrianus Cornelis | 29 |
#2 | Henning Robert Henk | 20 |
#3 | Euverink Gerrit Jan Willem | 19 |
#4 | Heeres Andre | 10 |
#5 | Seerden Johannes Paulus Gerardus | 10 |
#6 | Schmidt Martina | 7 |
#7 | Deelman Leo Edwin | 7 |
#8 | Meurs Hermanus | 7 |
#9 | Adrianus Cornelis Van Der Graaf | 5 |
#10 | Krenning Guido | 5 |
Publication | Filing date | Title |
---|---|---|
US2020206235A1 | 6-chromanol derivatives for use as a medicament | |
EP3672593A1 | Medicaments for the treatment of vasoconstriction related diseases or disorders | |
US2018170892A1 | Compound for the prophylaxis or treatment of organ damage | |
NL2013012B1 | Compounds for the treatment of chronic obstructive airway diseases. | |
NL2010010C2 | Compounds for protection of cells. | |
EP2557915A1 | Compounds for prevention of cell injury |